Trials / Unknown
UnknownNCT05118646
Comparison of Microcirculation Indexes and Hemodynamic Indexes to Guide Resuscitation in Patients With Septic Shock
Comparison of Microcirculation Indexes and Hemodynamic Indexes to Guide Early Fluid Resuscitation in Patients With Septic Shock
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 62 (estimated)
- Sponsor
- Xiangya Hospital of Central South University · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
Comparison of Microcirculation Indexes and Hemodynamic Indexes to Guide Resuscitation in Patients With Septic Shock
Detailed description
Objectives: Comparison of microcirculation indexes and hemodynamic indexes to guide resuscitation in patients with septic shock. Intervention: 1. Microcirculation-oriented resuscitation group: When the system hemodynamics meets the standard of EDGT, the microcirculation-oriented resuscitation group will evaluate the organ perfusion level and adjust the hemodynamic therapy according to the sublingual microcirculation parameters (PPV \> 68%). 2. Control group: The standard treatment group will adjust the shock management scheme through systemic hemodynamic parameters. Primary outcome: (1)change in SOFA score at 72h (2)30-day mortality
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | sublingual microcirculation, | Avoiding pressure artifacts, clear stable microvascular images were taken for a minimum of 20 seconds of the left, middle, and right sections of the tongue. |
| DEVICE | hemodynamic monitoring | Arterial blood lactic acid (Lac), central venous oxygen saturation (ScvO2), hematocrit (HCT) and entral venous-to-arterial carbon dioxide partial pressure difference (Pcv-aCO2) will be measured employing a bedside blood gas machine on admission and six hours following admission. |
Timeline
- Start date
- 2020-12-01
- Primary completion
- 2021-12-01
- Completion
- 2021-12-30
- First posted
- 2021-11-12
- Last updated
- 2021-11-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05118646. Inclusion in this directory is not an endorsement.